非凡領越(00933.HK)首日轉主板買賣 收報1.54元
非凡領越(00933.HK)今日(27日)起轉主板買賣,該股收報1.54元,升4.8%,成交692.4萬股,涉資1,048萬元。
集團主席、行政總裁兼執行董事李寧在上一份年報的展望中表示,相信通過對產品組合和銷售渠道的優化,加上品牌自身的實力,可以進一步提昇在歐美市場份額。
非凡集團為消費品品牌運營商,旗下擁有多個國際知名的服裝及鞋履品牌,包括英國著名鞋履品牌Clarks、意大利奢侈皮具品牌Amedeo Testoni、中港知名休閒品牌堡獅龍和bossini.X、輕奢潮品牌LNG及內衣品牌內莊。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.